Popular New
- Hematopoietic cell transplant in pediatric acute myeloid leukemia after similar upfront therapy; a comparison of conditioning regimens.529 daysVettenranta, K(im) (PRC)*Read
- Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study.563 daysVettenranta, K(im) (PRC)*Read
- Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting.565 daysVettenranta, K(im) (PRC)*Read
- Relapse risk following truncation of PEG-asparaginase in childhood acute lymphoblastic leukemia.605 daysVettenranta, K(im) (PRC)*Read
- Preterm birth, neonatal therapies and the risk of childhood cancer.610 daysVettenranta, K(im) (PRC)*Read
- ABO incompatibile graft management in pediatric transplantation.733 daysVettenranta, K(im) (PRC)*Read
- Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study.832 daysVettenranta, K(im) (PRC)*Read
- Acute toxicity and outcome among pediatric allogeneic hematopoietic transplant patients conditioned with treosulfan-based regimens.842 daysVettenranta, K(im) (PRC)*Read
- Pediatric acute graft-versus-host disease prophylaxis and treatment: Real-life approach reveals dissimilarities compared to published recommendations.850 daysVettenranta, K(im) (PRC)*Read
- Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantati877 daysVettenranta, K(im) (PRC)*Read
- Maternal Diabetes and Risk of Childhood Cancer in the Offspring.979 daysVettenranta, K(im) (PRC)*Read
- T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol.992 daysVettenranta, K(im) (PRC)*Read
- Neurologic disorders in long-term survivors of neuroblastoma - a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) research program.999 daysVettenranta, K(im) (PRC)*Read
- Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study.1178 daysVettenranta, K(im) (PRC)*Read
- Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience.1254 daysVettenranta, K(im) (PRC)*Read
- Stem cell transplantation for congenital dyserythropoietic anemia. An analysis from the European society for blood and marrow transplantation.1254 daysVettenranta, K(im) (PRC)*Read
- Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.1296 daysVettenranta, K(im) (PRC)*Read
- Somatic late effects in 5-year survivors of neuroblastoma: A population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study.1473 daysVettenranta, K(im) (PRC)*Read
- Graft-versus-host disease in stem cell transplantation.1671 daysVettenranta, K(im) (PRC)*Read
- Individualized 6-mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: a NOPHO randomized controlled trial.1731 daysVettenranta, K(im) (PRC)*Read
- Results of NOPHO ALL2008 treatment for patients 1-45 years with acute lymphoblastic leukemia.1780 daysVettenranta, K(im) (PRC)*Read
- Long Term Outcomes of Cord Blood Transplantation From an HLA-Identical Sibling for Patients with Bone Marrow Failure Disorders: a Report From Eurocord, Cord Blood Committee (CBC-CTIWP) and Severe Aplastic Anemia Working Party (SAAWP) of the European1787 daysVettenranta, K(im) (PRC)*Read
- Haematopoietic stem cell transplantation induces severe dysbiosis in intestinal microbiota of paediatric ALL patients.1791 daysVettenranta, K(im) (PRC)*Read
- Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group.1805 daysVettenranta, K(im) (PRC)*Read
- Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic Leukemia.1805 daysVettenranta, K(im) (PRC)*Read
- Salvage high-dose chemotherapy in female patients with relapsed/refractory germ cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT).1874 daysVettenranta, K(im) (PRC)*Read
- Children with low-risk acute lymphoblastic leukemia are at highest risk of second cancers.1877 daysVettenranta, K(im) (PRC)*Read
- State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Trans1938 daysVettenranta, K(im) (PRC)*Read
- Hepatotoxicity During Maintenance Therapy and Prognosis in Children With Acute Lymphoblastic Leukemia.2004 daysVettenranta, K(im) (PRC)*Read
- Good responses but high TRM in adult patients after MSC therapy for GvHD.2028 daysVettenranta, K(im) (PRC)*Read
- Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters.2069 daysVettenranta, K(im) (PRC)*Read
- Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia.2081 daysVettenranta, K(im) (PRC)*Read
- Maintenance therapy of childhood acute lymphoblastic leukemia revisited-Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?2082 daysVettenranta, K(im) (PRC)*Read
- Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.2089 daysVettenranta, K(im) (PRC)*Read
- Speckle tracking echocardiography detects decreased cardiac longitudinal function in anthracycline-exposed survivors of childhood cancer.2119 daysVettenranta, K(im) (PRC)*Read
- Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia.2134 daysVettenranta, K(im) (PRC)*Read
- Viremic co-infections in children with allogeneic haematopoietic stem cell transplantation are predominated by human polyomaviruses.2163 daysVettenranta, K(im) (PRC)*Read
- Maintenance therapy of childhood acute lymphoblastic leukemia revisited-Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?2163 daysVettenranta, K(im) (PRC)*Read
- Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters.2197 daysVettenranta, K(im) (PRC)*Read
- Single-centre study reports a 84% five-year overall survival rate for paediatric solid tumors.2275 daysVettenranta, K(im) (PRC)*Read
- Polyomaviruses BK, JC, KI, WU, MC, and TS in children with allogeneic hematopoietic stem cell transplantation.2282 daysVettenranta, K(im) (PRC)*Read
- Parents' and Adolescents' Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials.2375 daysVettenranta, K(im) (PRC)*Read
- Toxicity profile and treatment delays in NOPHO ALL2008 - comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.2638 daysVettenranta, K(im) (PRC)*Read
- Surgically treated patients with axial and peripheral Ewing's sarcoma family of tumours: A population based study in Finland during 1990-2009.2652 daysVettenranta, K(im) (PRC)*Read
- Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning.2652 daysVettenranta, K(im) (PRC)*Read
- Incidence, treatment and survival of paediatric patients with bone sarcomas in Finland from 1991-2005.2683 daysVettenranta, K(im) (PRC)*Read
- [Solid tumors in children].2735 daysVettenranta, K(im) (PRC)*Read
- [Childhood and adolescent cancer was cured--how to support health in adulthood?].2735 daysVettenranta, K(im) (PRC)*Read
- Diffuse gastrointestinal bleeding and BK polyomavirus replication in a pediatric allogeneic haematopoietic stem cell transplant patient.2743 daysVettenranta, K(im) (PRC)*Read
- Cardiac biomarkers indicate a need for sensitive cardiac imaging among long-term childhood cancer survivors exposed to anthracyclines.2789 daysVettenranta, K(im) (PRC)*Read

- Medicine - All Feeds
- Allergology and Immunology
- Anatomy and Physiology
- Anesthesiology and Intensive Care
- Biochemistry
- Bioengineering
- Biophysics
- Biotechnology
- Cardiology
- Cardiothoracic Surgery
- Clinical Chemistry
- Clinical Medicine
- Complementary Medicine
- Cytology and Histology
- Dentistry
- Dermatology
- Endocrinology
- Forensic Medicine
- Gastroenterology
- General Practice
- Genetics
- Geriatrics
- Health services and Administration
- Hematology
- Infectious Diseases
- Internal Medicine
- Logopedics
- Medical Education and Humanities
- Medical Microbiology
- Medicine - Other
- Nephrology
- Neurology
- Neurosurgery
- Nursing
- Nutritional Sciences
- Obstetrics and Gynecology
- Occupational Health
- Oncology
- Ophthalmology
- Oral and Maxillofacial Surgery
- Orthopedics and Traumatology
- Otorhinolaryngology and Phoniatrics
- Pathology
- Pediatrics
- Pharmacology and Pharmacotherapy
- Physical and Rehabilitation Medicine
- Plastic Surgery
- Psychiatry
- Psychology
- Public Health
- Radiology
- Respiratory Medicine
- Rheumatology
- Sports Medicine
- Surgery
- Urology